ERO1L Antikörper (AA 105-118)
Kurzübersicht für ERO1L Antikörper (AA 105-118) (ABIN5539459)
Target
Alle ERO1L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- AA 105-118
-
Verwendungszweck
- ERO1-like (aa105-118)
-
Sequenz
- QSDEVPDGIK SASY
-
Kreuzreaktivität
- Rind (Kuh), Hund, Human, Maus, Schwein, Ratte
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Small Intestine. Recommended concentration: 5 μg/mL.
Western Blot: Approx 70 kDa band observed in lysates of cell lines A431, HeLa, Jurkat (calculated MW of 54.4 kDa according to NP_055399.1). The observed molecular weight corresponds to the glycosylated form. Recommended concentration: 0.1-0.3 μg/mL. Primary
Peptide ELISA: antibody detection limit dilution 1:32000.
-
Kommentare
-
Additional validation: This antibody has been successfully used in the following paper: Sikorski et al. (2018) PMID: 30377371.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- ERO1L (ERO1-Like Protein alpha (ERO1L))
-
Andere Bezeichnung
- ERO1L
-
Hintergrund
- ERO1L, ERO1-like (S. cerevisiae), ERO1-alpha, ERO1-L, ERO1-L-alpha, ERO1-like protein alpha, endoplasmic oxidoreductin-1-like protein, oxidoreductin-1-L-alpha
-
Gen-ID
- 30001
-
NCBI Accession
- NP_055399
-
Pathways
- Peptide Hormone Metabolism, ER-Nucleus Signaling, Brown Fat Cell Differentiation
Target
-